Merck & Company (MRK) reported its Q2 2026 financial results before the market opened on August 4, 2026. The company reported revenue of 16607 million USD and an EPS of -0.13 USD, beating the analyst estimate of -0.27 USD by 51.9%. Following the release, the stock price reacted with a gain of +0.18%.
Generated automatically from our data — as of August 12, 2026
Key figures at a glance
Estimate (EPS): -0.27 USD
Reported (EPS): -0.13 USD
Price reaction: +0.2%
Frequently asked questions
Did Merck & Company beat or miss earnings-per-share expectations?
Merck & Company beat the analyst estimate of -0.27 USD earnings per share (Q2 2026) by 51.9%, reporting -0.13 USD.
How did Merck & Company stock react to the earnings report?
Merck & Company stock rose 0.2% on the trading day following the release.
What was Merck & Company's revenue in Q2 2026?
Merck & Company reported revenue of 16,607M USD in Q2 2026.